Evidence map›Paper›PMID 36200598›Full record

ArticleRedox report : communications in free radical research2022

Atorvastatin-mediated downregulation of VCAM-1 and XO/UA/caspase 3 signaling averts oxidative damage and apoptosis induced by ovarian ischaemia/reperfusion injury.

O A Afolabi, M A Hamed, D C Anyogu, D H Adeyemi, A F Odetayo, R E Akhigbe

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

O A AfolabiDepartment of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
M A HamedBrainwill Laboratories, Osogbo, Nigeria.
D C AnyoguDepartment of Veterinary Pathology and Microbiology, University of Nigeria, Nsukka, Nigeria.
D H AdeyemiDepartment of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, Osun State University, Osogbo, Nigeria.
A F OdetayoReproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Nigeria.
R E AkhigbeDepartment of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.ORCID 0000-0002-3874-5927
Ladoke Akintola University of Technology · NGOsun State University · NGUniversity of Ilorin · NGUniversity of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxidative damage is critical in the pathogenesis of ovarian ischaemia/reperfusion (I/R) injury, and statins have been reported to exert antioxidant activity. However, the role of VCAM-1 and xanthine oxidase (XO)/uric acid (UA) in ovarian I/R injury is not known. Also, whether or not atorvastatin exerts antioxidant activity like other statins is unclear.

objectivesThis study investigated the involvement of VCAM-1 and XO/UA in ovarian I/R injury and the likely protective role of atorvastatin.

methodsForty female Wistar rats were randomized into sham-operated, ischaemia, ischaemia/reperfusion (I/R), ischaemia and atorvastatin, and I/R and atorvastatin.

resultsIn comparison with the sham-operated group, atorvastatin blunted ischaemia and I/R-induced distortion of ovarian histoarchitecture and follicular degeneration. Also, atorvastatin alleviated ischaemia and I/R-induced rise in XO, UA, and malondialdehyde, which was accompanied by inhibition of ischaemia and I/R-induced reductions in reduced glutathione level, enzymatic antioxidant activities and increase in myeloperoxidase activity and TNF-α and IL-6 levels by atorvastatin treatment. Additionally, atorvastatin blocked ischaemia and I/R-induced increase in VCAM-1 expression, caspase 3 activity, 8-hydroxydeoxyguanosine level and ovarian DNA fragmentation index.

conclusionFor the first time, this study revealed that atorvastatin-mediated downregulation of VCAM-1 and XO/UA/caspase 3 signaling averts oxidative injury, inflammation, and apoptosis induced by ovarian ischaemia/reperfusion injury.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsReperfusion Injury8-Hydroxy-2'-DeoxyguanosineAnimalsAntioxidantsApoptosisAtorvastatinCaspase 3Down-RegulationFemaleGlutathioneInterleukin-6IschemiaMalondialdehydeOxidative StressPeroxidase8-Hydroxy-2'-DeoxyguanosineAntioxidantsAtorvastatinCaspase 3GlutathioneHydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-6MalondialdehydePeroxidaseTumor Necrosis Factor-alphaUric AcidVascular Cell Adhesion Molecule-1Xanthine OxidaseAdhesion moleculesfolliculogenesisinflammation‌ischaemia/reperfusion‌oocyteovarystatins‌torsion/detorsion

Identifiers

PMID36200598
PMCPMC9553180
OpenAlexW4302760588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.